Here’s what you should know.
Mr. Saunders said the company aligned with the “priorities of the incoming Trump administration.”
He added the company intends to create more jobs in the United States to fuel the economy.
More articles on gastroenterology/endoscopy:
Exact Sciences, Takeda Pharmaceuticals & more — 6 GI company key notes
GI leader to know: Dr. Deborah Blalock of Blalock GI Care
How investors reacted to Valeant’s $2.1B sell off: 4 key insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.